Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OM Outset Medical Inc
- Stocks
- Healthcare
- NASDAQ: OM
Price (delayed)
$19.5
Market cap
$345.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$29.01
Enterprise value
$364.5M
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to
Highlights
The equity has soared by 82% YoY
OM's quick ratio has surged by 54% since the previous quarter and by 27% year-on-year
Outset Medical's revenue has decreased by 8% YoY
Key stats
What are the main financial stats of OM
Market
Valuations
Earnings
Shares outstanding
17.72M
Market cap
$345.59M
Enterprise value
$364.5M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.41
Price to sales (P/S)
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.16
Revenue
$115.27M
Gross profit
$41.42M
Operating income
-$92.86M
Net income
-$113.82M
EBIT
-$91.91M
EBITDA
-$84.88M
Free cash flow
-$96.74M
Per share
Balance sheet
Liquidity
EPS
-$29.01
EPS diluted
-$29.01
Free cash flow per share
-$13.74
Book value per share
$47.28
Revenue per share
$16.38
TBVPS
$42.8
Total assets
$301.21M
Total liabilities
$131.34M
Debt
$98.17M
Equity
$169.87M
Working capital
$252.34M
Debt to equity
0.58
Current ratio
8.37
Quick ratio
6.7
Net debt/EBITDA
-0.22
Margins
Efficiency
Dividend
EBITDA margin
-73.6%
Gross margin
35.9%
Net margin
-98.7%
Operating margin
-80.6%
Return on assets
-38.4%
Return on equity
-145.4%
Return on invested capital
-25.5%
Return on capital employed
-34.4%
Return on sales
-79.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OM stock price
How has the Outset Medical stock price performed over time
Intraday
-0.26%
1 week
27.45%
1 month
78.74%
1 year
-63.07%
YTD
17.12%
QTD
76.31%
Financial performance
How have Outset Medical's revenue and profit performed over time
Revenue
$115.27M
Gross profit
$41.42M
Operating income
-$92.86M
Net income
-$113.82M
Gross margin
35.9%
Net margin
-98.7%
OM's gross margin is up by 46% year-on-year and by 6% since the previous quarter
Outset Medical's operating income has increased by 43% YoY and by 18% QoQ
The operating margin has grown by 38% year-on-year and by 19% since the previous quarter
OM's gross profit is up by 35% year-on-year and by 7% since the previous quarter
Price vs fundamentals
How does OM's price correlate with its fundamentals
Growth
What is Outset Medical's growth rate over time
Valuation
What is Outset Medical stock price valuation
P/E
N/A
P/B
0.41
P/S
1.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.16
OM's EPS is up by 43% year-on-year and by 21% since the previous quarter
OM's price to book (P/B) is 90% lower than its 5-year quarterly average of 4.0 and 73% lower than its last 4 quarters average of 1.5
The equity has soared by 82% YoY
OM's price to sales (P/S) is 89% lower than its 5-year quarterly average of 11.3 but 49% higher than its last 4 quarters average of 0.8
Outset Medical's revenue has decreased by 8% YoY
Efficiency
How efficient is Outset Medical business performance
The return on invested capital has increased by 39% year-on-year
OM's return on sales is up by 35% year-on-year and by 13% since the previous quarter
Outset Medical's ROE has increased by 33% from the previous quarter but it has decreased by 19% YoY
Outset Medical's return on assets has increased by 26% YoY and by 8% QoQ
Dividends
What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OM.
Financial health
How did Outset Medical financials performed over time
The total assets is 129% greater than the total liabilities
OM's quick ratio has surged by 54% since the previous quarter and by 27% year-on-year
The total liabilities has declined by 48% year-on-year and by 47% since the previous quarter
OM's debt is 42% less than its equity
The debt to equity has dropped by 92% since the previous quarter and by 73% year-on-year
The equity has soared by 82% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.